PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Mar-2023 Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership Evotec SE
28-Mar-2023 Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership Evotec SE
28-Mar-2023 Vantage Nutrition LLC acquires ComboCap Inc Vantage Nutrition
28-Mar-2023 DEFENCE TO COMPLETE A FINAL PRE-CLINICAL STUDY PRIOR TO IND FILINGS FOR THE ACCUTOXTM PHASE I CANCER TRIAL AT THE CITY OF HOPE NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE Defence Therapeutics Inc.
28-Mar-2023 Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory Dermapharm Holding SE
28-Mar-2023 Evolva goes Responsible Care at in-cosmetics 2023 Evolva Holding SA
28-Mar-2023 SKAN Group continues growth trajectory in financial year 2022 SKAN AG
28-Mar-2023 Evotec SE preliminary fiscal year 2022 results: 'Ahead of the curve' – very strong performance in a challenging year Evotec SE
27-Mar-2023 Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board Sartorius Stedim Biotech SA
27-Mar-2023 Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases Secarna Pharmaceuticals GmbH & Co. KG
27-Mar-2023 Uni-Bio Science Group Limited: 2022 Annual Results UNI-BIO SCIENCE GROUP LIMITED
27-Mar-2023 Vitruvia Medical AG: auhtorised capital increase Vitruvia Medical AG
27-Mar-2023 Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme Apogenix AG
27-Mar-2023 Grünenthal GmbH: Grünenthal reports record revenue and profit in 2022 full-year results and strong pipeline progress (news with additional features) Grünenthal GmbH
27-Mar-2023 Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea Biophytis
27-Mar-2023 Lonza Publishes Invitation to the 2023 Annual General Meeting and 2022 Annual and Sustainability Reports Lonza Group AG
24-Mar-2023 MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6) MorphoSys AG
24-Mar-2023 ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE) Eckert & Ziegler Strahlen- und Medizintechnik AG
24-Mar-2023 Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis Evotec SE
24-Mar-2023 Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business Heidelberg Pharma AG